We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+1.97%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$38.4B
AUM Growth
–
Cap. Flow
+$38.8B
Cap. Flow
% of AUM
101.16%
Top 10 Holdings %
Top 10 Hldgs %
42.4%
Holding
647
New
644
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.97B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.85B |
| 3 |
Microsoft
MSFT
|
+$1.85B |
| 4 |
Coca-Cola
KO
|
+$1.74B |
| 5 |
Pfizer
PFE
|
+$1.69B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.54% |
| 2 | Healthcare | 24.15% |
| 3 | Technology | 21.66% |
| 4 | Communication Services | 6.6% |
| 5 | Energy | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Qualcomm
QCOM
$176B
| $351M | 0.91% |
+5,749,913
| New | +$367M |
|
27
Bristol-Myers Squibb
BMY
$127B
| $339M | 0.88% |
+7,577,933
| New | +$329M |
|
|
LO
28
DELISTED
LORILLARD INC COM STK
LO
| $311M | 0.81% |
+7,114,583
| New | +$304M |
|
29
Eli Lilly
LLY
$1.07T
| $307M | 0.8% |
+6,254,352
| New | +$340M |
|
30
Nike
NKE
$61.9B
| $286M | 0.74% |
+8,972,266
| New | +$279M |
|
31
Mastercard
MA
$477B
| $282M | 0.74% |
+4,916,490
| New | +$273M |
|
32
iShares MSCI Emerging Markets ETF
EEM
$28B
| $270M | 0.7% |
+7,006,358
| New | +$291M |
|
33
Visa
V
$677B
| $254M | 0.66% |
+5,560,980
| New | +$243M |
|
34
Zimmer Biomet
ZBH
$17.7B
| $247M | 0.64% |
+3,393,943
| New | +$254M |
|
35
Amgen
AMGN
$203B
| $204M | 0.53% |
+2,066,387
| New | +$214M |
|
36
America Movil
AMX
$78.1B
| $191M | 0.5% |
+8,768,560
| New | +$179M |
|
37
Labcorp
LH
$24.3B
| $188M | 0.49% |
+2,182,505
| New | +$181M |
|
38
Vale
VALE
$62.9B
| $181M | 0.47% |
+13,745,351
| New | +$216M |
|
|
VALE.P
39
DELISTED
Vale S A
VALE.P
| $177M | 0.46% |
+14,590,623
| New | +$216M |
|
40
Sysco
SYY
$39.7B
| $176M | 0.46% |
+5,161,766
| New | +$178M |
|
41
Copa Holdings
CPA
$5.56B
| $155M | 0.4% |
+1,180,442
| New | +$151M |
|
42
JPMorgan Chase
JPM
$939B
| $153M | 0.4% |
+2,897,396
| New | +$147M |
|
43
Kimberly-Clark
KMB
$36.4B
| $153M | 0.4% |
+1,637,779
| New | +$158M |
|
44
Baxter International
BAX
$11.6B
| $148M | 0.38% |
+3,925,423
| New | +$150M |
|
45
Costco
COST
$415B
| $147M | 0.38% |
+1,325,158
| New | +$145M |
|
|
EMC
46
DELISTED
EMC CORPORATION
EMC
| $138M | 0.36% |
+5,823,100
| New | +$137M |
|
47
Citigroup
C
$222B
| $132M | 0.34% |
+2,750,358
| New | +$132M |
|
48
CVS Health
CVS
$137B
| $132M | 0.34% |
+2,306,974
| New | +$134M |
|
49
Gilead Sciences
GILD
$161B
| $130M | 0.34% |
+2,530,605
| New | +$132M |
|
50
Becton Dickinson
BDX
$43.1B
| $127M | 0.33% |
+1,322,286
| New | +$126M |
|
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Grantham, Mayo, Van Otterloo & Co (GMO), which disclosed 647 positions worth $38.4B. Its ten largest holdings account for 42% of the portfolio.
Its largest position is Johnson & Johnson: 23,171,691 shares worth $1.99B.
By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, followed by Healthcare and Technology.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2013 buy was Johnson & Johnson: 23,171,691 shares worth $1.99B.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 42% of its $38.4B portfolio in Q2 2013.
- Grantham, Mayo, Van Otterloo & Co (GMO) disclosed 647 positions in Q2 2013, its first 13F filing on record.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2013, filed 13 Aug 2013.